Gurbel; Paul A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gurbel; Paul A..The latest application filed is for "detection of restensosis risk in patients receiving a stent".

Company Profile

2.23.18

Gurbel; Paul A. - Baltimore MD
Gurbel; Paul A. - US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Detection of restensosis risk in patients receiving a stent Grant 10,942,192 - Gurbel March 9, 2	2021-03-09
Assessment of cardiac health and thrombotic risk in a patient Grant 10,660,942 - Gurbel	2020-05-26
Detection Of Restensosis Risk In Patients Receiving A Stent App 20190137525 - Gurbel; Paul A.	2019-05-09
Detection of restensosis risk in patients receiving a stent Grant 10,139,421 - Gurbel Nov	2018-11-27
Assessment of Cardiac Health and Thrombotic Risk in a Patient App 20180153966 - Gurbel; Paul A.	2018-06-07
Assessment of cardiac health and thrombotic risk in a patient Grant 9,789,166 - Gurbel October 17, 2	2017-10-17
Detection Of Restensosis Risk In Patients Receiving A Stent App 20170292965 - Gurbel; Paul A.	2017-10-12
The Detection Of Restenosis Risk In Patients Receiving A Stent App 20160069914 - Gurbel; Paul A.	2016-03-10
Assessment Of Cardiac Health And Thrombotic Risk In A Patient App 20160067313 - Gurbel; Paul A.	2016-03-10
Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength Grant 9,188,597 - Gurbel November 17, 2	2015-11-17
Assessment of cardiac health and thrombotic risk in a patient Grant 9,110,062 - Gurbel August 18, 2	2015-08-18
Assessment Of Cardiac Health And Thrombotic Risk In A Patient App 20140100167 - Gurbel; Paul A.	2014-04-10
Assessment of cardiac health and thrombotic risk in a patient Grant 8,440,420 - Gurbel May 14, 2	2013-05-14
Detection Of Restenosis Risk In Patients Receiving A Stent By Measuring The Characteristics Of Blood Clotting Including The Measurement Of Maximum Thrombin-induced Clot Strength App 20120264150 - Gurbel; Paul A.	2012-10-18
Assessment of Cardiac Health and Thrombotic Risk in a Patient App 20120115784 - Gurbel; Paul A.	2012-05-10
Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength Grant 8,070,678 - Gurbel December 6, 2	2011-12-06
Assessment of cardiac health and thrombotic risk in a patient Grant 8,058,023 - Gurbel November 15, 2	2011-11-15
Detection of restenosis risk in patients receiving a stent by measuring the characteristics of blood clotting including the measurement of maximum thrombin-induced clot strength App 20090198120 - Gurbel; Paul A.	2009-08-06
Assessment Of Cardiac Health And Thrombotic Risk In A Patient App 20090123465 - Gurbel; Paul A.	2009-05-14
Assessment of cardiac health and thrombotic risk in a patient Grant 7,381,536 - Gurbel June 3, 2	2008-06-03
Assessment of cardiac health and thrombotic risk in a patient App 20060199239 - Gurbel; Paul A.	2006-09-07
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors Grant 6,552,014 - Serebruany , et al. April 22, 2	2003-04-22
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors App 20020013343 - Serebruany, Victor L. ; et al.	2002-01-31
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors Grant 6,245,782 - Serebruany , et al. June 12, 2	2001-06-12
Autoperfusion dilatation catheter having a bonded channel Grant 5,295,959 - Gurbel , et al. March 22, 1	1994-03-22

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.